focus -WSS

focus

author：fashion 2025-09-06 01:58:58 - browse：74626

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Achieving telehealth equity for people with hearing loss

WSS

The world needs the new pandemic treaty

Stroke rates rising, especially in working

A new ‘biological computer' targets cancer while sparing healthy cells

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Stanford president’s abrupt resignation sparks debate

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

After affirmative action ruling, medical educators look to 'holistic review'

US jobless claims fall again as labor market continues to flash strength

New air purifier tech could be key to improving indoor air quality

Why some fertility treatments produce more boy babies

At least 13 dead in Texas as scorching temps continue

Judge denies Trump's request for new trial in E. Jean Carroll case

How to save PrEP access — and even expand it

Extensive review finds private equity owners jack up cost of care

Hepatitis C has a cure — but many Americans still lack access to it

Extensive review finds private equity owners jack up cost of care

knowledge

Unmasking the 'centricity' illusion in clinical trials

Some medical students still think black patients feel less pain

Achieving telehealth equity for people with hearing loss

When a patient nears the end, a feared therapy can comfort

Are infertility treatments 'essential' during the Covid

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

knowledge

entertainment

hotspot

focus